mediCAD® is a German-based company founded in 1989, offering innovative software solutions and services for joint replacement & preservation in 2D (Xray), 3D (CT) and mixed reality. The company provides medical software that ensures a high level of planning and operational quality for orthopedic surgeons worldwide. Its extensive prosthesis template library and planning tools enable surgeons to create detailed pre-operative plans quickly and easily from digital x-ray images. mediCAD's cutting-edge technology facilitates digital planning and templating for various orthopedic procedures, making it a preferred choice in hospitals across the globe. With its focus on Health Care and Information Technology, mediCAD stands out as a leader in the medical software industry. While the specific details of its last investment and the involved investors are currently unavailable, mediCAD's commitment to advancing orthopedic surgery through state-of-the-art software solutions is evident. The company's global presence and dedication to film-free radiology pre-op preparation position it as a significant player in the market. Overall, mediCAD's track record, industry focus, and technological advancements make it an intriguing prospect for potential investors seeking opportunities in the healthcare and IT sectors. Its comprehensive solutions and global reach demonstrate the potential for continued growth and impact in the orthopedic surgery industry, making it a noteworthy consideration for venture capital investment. For further insights and potential investment opportunities, reaching out to mediCAD directly at [email protected] for a personal demo could provide valuable firsthand experience of the company's offerings.
There is no investment information
No recent news or press coverage available for mediCAD®.